Your browser doesn't support javascript.
loading
Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV.
Barnabas, Shaun L; Dabee, Smritee; Passmore, Jo-Ann S; Jaspan, Heather B; Lewis, David A; Jaumdally, Shameem Z; Gamieldien, Hoyam; Masson, Lindi; Muller, Etienne; Maseko, Venessa D; Mkhize, Nonhlanhla; Mbulawa, Zizipho; Williamson, Anna-Lise; Gray, Clive M; Hope, Thomas J; Chiodi, Francesca; Dietrich, Janan; Gray, Glenda; Bekker, Linda-Gail.
Afiliação
  • Barnabas SL; 1 Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Dabee S; 2 Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
  • Passmore JS; 1 Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Jaspan HB; 1 Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Lewis DA; 3 National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.
  • Jaumdally SZ; 4 DST-NRF CAPRISA Centre of Excellence in HIV Prevention, University of Cape Town, Cape Town, South Africa.
  • Gamieldien H; 1 Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Masson L; 5 145793 Seattle Children's Research Institute , University of Washington, Seattle, WA, USA.
  • Muller E; 6 Western Sydney Sexual Health Centre, Western Sydney Local Health District, Parramatta, Australia.
  • Maseko VD; 7 Centre for Infectious Diseases and Microbiology & Marie Bashir Institute for Infectious Diseases and Biosecurity, Westmead Clinical School, University of Sydney, Sydney, Australia.
  • Mkhize N; 8 Centre for HIV and STIs, 70687 National Institute for Communicable Disease , National Health Laboratory Service, Johannesburg, South Africa.
  • Mbulawa Z; 1 Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Williamson AL; 4 DST-NRF CAPRISA Centre of Excellence in HIV Prevention, University of Cape Town, Cape Town, South Africa.
  • Gray CM; 1 Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Hope TJ; 3 National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.
  • Chiodi F; 1 Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Dietrich J; 3 National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.
  • Gray G; 8 Centre for HIV and STIs, 70687 National Institute for Communicable Disease , National Health Laboratory Service, Johannesburg, South Africa.
  • Bekker LG; 8 Centre for HIV and STIs, 70687 National Institute for Communicable Disease , National Health Laboratory Service, Johannesburg, South Africa.
Int J STD AIDS ; 29(6): 531-539, 2018 05.
Article em En | MEDLINE | ID: mdl-29198180
Adolescents in Africa are at high risk for HIV infection, other sexually transmitted infections (STIs) and bacterial vaginosis (BV). Since behavior and burden of STIs/BV may influence HIV risk, behavioral risk factors and prevalence of STIs/BV were compared in HIV-seronegative adolescent females (n = 298; 16-22 years) from two South African communities (Soweto and Cape Town). STIs ( Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, herpes simplex virus (HSV)-1, HSV-2, Treponema pallidum, and Haemophilus ducreyi) were detected by multiplex polymerase chain reaction, human papillomavirus (HPV) by Roche Linear Array, and BV by Nugent scoring. Rates of BV (Nugent ≥7; 46.6%) and HPV (66.8%) were high in both communities. Prevalence of C. trachomatis and N. gonorrhoeae were >2-fold higher in Cape Town than Soweto (Chlamydia: 42% [62/149] versus 18% [26/148], p < 0.0001; gonorrhoea 11% [17/149] versus 5% [7/148], p = 0.05). Only 24% of adolescents with vaginal discharge-causing STIs or BV were symptomatic. In South African adolescents, clinical symptoms compatible with vaginal discharge syndrome had a sensitivity of 23% and specificity of 85% for the diagnosis of discharge-causing STI or BV. In a region with high HIV prevalence and incidence, >70% of young women with treatable conditions that could enhance HIV risk would have been missed because they lacked symptoms associated with syndromic management.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Sexualmente Transmissíveis / Infecções por HIV / Vaginose Bacteriana / Soronegatividade para HIV / Epidemias Tipo de estudo: Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Sexualmente Transmissíveis / Infecções por HIV / Vaginose Bacteriana / Soronegatividade para HIV / Epidemias Tipo de estudo: Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article